We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Treatments for Bone Tumor Pain

By HospiMedica staff writers
Posted on 22 Apr 2005
Studies have shown that three nonsurgical treatments reduced the severe pain caused by bone tumors by 74-89% in patients for whom conventional treatments were not effective. More...


The three techniques are osteoplasty, radiofrequency ablation, and cryoablation. These heat or freeze the tumor, killing the nerve endings that cause the pain. Cancer often metastasizes to bone, and can cause terrible pain that is unrelieved by narcotics and other standard pain treatments. While radiation reduces pain in about 70% of patients, the pain often returns or increases over time, and further radiation is often not possible because it would damage healthy tissue. In addition, radiation can take five to 20 weeks to work.

"Pain affects greater than 60% of patients with advanced cancer and for many, the pain isn't due to bone metastases,” remarked Matthew Callstrom, M.D., Ph.D., an interventional radiologist at Mayo Clinic (Rochester, MN, USA; www.mayoclinic.com). "This research shows these new interventional techniques are effective to help these patients without surgery, and offer a short recovery time.”

Osteoplasty treats bone pain by injecting medical-grade bone cement into the tumor. The cement gives off heat and then hardens to reinforce weakened bone that otherwise would be susceptible to fracture. This is an established technique used to treat painful vertebral metastases or fractures in the spine from osteoporosis. Most frequently, this is an outpatient procedure performed using conscious sedation. A study showed osteoplasty was effective in all eight patients enrolled, who experienced prompt and lasting pain relief with no significant complications.

Cryoablation probes have become smaller and are now insulated, so they can be inserted through a small nick in the skin, without the need for an operation or stitches. Of 10 patients in a recent study, 80% had an average 74% reduction in their worst pain.

Radiofrequencing ablation (RFA) delivers heat directly into the tumor via a probe that is inserted through the skin, using computed tomography (CT) and ultrasound imaging for guidance. From the tip of the needle, radiofrequency energy is transmitted into the targeted tissue, where it produces heat and kills the tumor. Pain relief was achieved within a week for all of the 11 patients who underwent RFA.




Related Links:
Mayo Clinic

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.